-transparent.png){kind=logo}
The effect of cyclosporin A on induction of nitric oxide synthase in rat aortic smooth muscle cells was examined. A combination of interleukin-1 alpha (100 U/mL) and tumor necrosis factor--alpha (5000 U/mL) induced accumulation of nitrite/nitrate, the stable end products of nitric oxide, in culture media within 48 hours. Cyclosporin A inhibited this nitrite/nitrate accumulation in a concentration-dependent manner with an IC50 of 4 x 10(-7) mol/L when applied simultaneously with the cytokines. The expression of inducible nitric oxide synthase messenger RNA (mRNA) induced by the combination of interleukin-1 alpha and tumor necrosis factor-alpha was inhibited by the cyclosporin A cotreatment. Cyclosporin A did not decrease inducible nitric oxide synthase mRNA stability in the presence of transcription inhibitor actinomycin D (5 micrograms/mL). Induction of nitrite/nitrate production by the combination of tumor necrosis factor-alpha and bacterial lipopolysaccharide or that of interleukin-1 alpha and interferon gamma (100 U/mL) was also inhibited by cyclosporin A cotreatment. Another inhibitor of calcineurin, FK506 (up to 10(-6) mol/L), had no effect on the induction of nitrite/nitrate production, suggesting the possibility that the inhibitory effect of cyclosporin A may be exerted by means of a novel pathway other than inhibition of calcineurin. These results indicate that cyclosporin A inhibits inducible nitric oxide synthase induction at the mRNA level and that inducible nitric oxide synthase in vascular smooth muscle cells can be a target for cyclosporin A, providing a possible mechanism for the interference of the drug with the balance of vasoactive substances.
T Marumo, and
T Nakaki, and
K Hishikawa, and
H Suzuki, and
R Kato, and
T Saruta
February 1993,
The American journal of physiology,
T Marumo, and
T Nakaki, and
K Hishikawa, and
H Suzuki, and
R Kato, and
T Saruta
November 1990,
FEBS letters,
T Marumo, and
T Nakaki, and
K Hishikawa, and
H Suzuki, and
R Kato, and
T Saruta
January 1994,
Circulation research,
T Marumo, and
T Nakaki, and
K Hishikawa, and
H Suzuki, and
R Kato, and
T Saruta
July 1993,
Hypertension (Dallas, Tex. : 1979),
T Marumo, and
T Nakaki, and
K Hishikawa, and
H Suzuki, and
R Kato, and
T Saruta
January 2000,
Hypertension (Dallas, Tex. : 1979),
T Marumo, and
T Nakaki, and
K Hishikawa, and
H Suzuki, and
R Kato, and
T Saruta
February 1998,
Circulation research,
T Marumo, and
T Nakaki, and
K Hishikawa, and
H Suzuki, and
R Kato, and
T Saruta
February 1994,
The Journal of clinical investigation,
T Marumo, and
T Nakaki, and
K Hishikawa, and
H Suzuki, and
R Kato, and
T Saruta
December 1995,
FEBS letters,
T Marumo, and
T Nakaki, and
K Hishikawa, and
H Suzuki, and
R Kato, and
T Saruta
April 2002,
FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
T Marumo, and
T Nakaki, and
K Hishikawa, and
H Suzuki, and
R Kato, and
T Saruta
March 1994,
Arzneimittel-Forschung,
